News & Events
Infectious Diseases Society of America Honors 219 Distinguished Physicians, Scientists
Infectious Diseases Society of America Honors 219 Distinguished Physicians, Scientists
Lucinda J. Van Anglen, B.S., Pharm.D., of Healix Infusion Therapy has been named a Fellow by the Infectious Diseases Society of America. Fellowship in IDSA is one of the highest honors in the field of infectious diseases. It recognizes distinguished physicians and...
Meet the Healix Team at IDWeek 2023
Meet the Healix Team at IDWeek 2023
Boston, MA We’re excited to announce that Healix will attend IDWeek 2023 in Boston! This premier infectious disease conference brings together clinicians, researchers, and healthcare professionals to share the latest advancements in patient care and disease...
High Adherence and Cost Savings with Home OPAT Provided Through Infectious Disease Physician Office Infusion Centers
High Adherence and Cost Savings with Home OPAT Provided Through Infectious Disease Physician Office Infusion Centers
SUGAR LAND, TX – (January 25, 2023) Outpatient parenteral antimicrobial therapy (OPAT) has been shown to be safe and effective for self-administration but can lead to non-adherence. OPAT provided through a physician office infusion center (POIC) with pharmacy...
National Organization of Rheumatology Management (NORM) 2022 Annual Conference
National Organization of Rheumatology Management (NORM) 2022 Annual Conference
Atlanta, GA The Healix Team is proud to participate as an exhibitor at the National Organization of Rheumatology Management 2022 Annual Conference on September 15-17, 2022, in Atlanta, Georgia. If you will be at the conference, we invite you to visit the Healix...
Transition to Subcutaneous Immune Globulin 16.5% Improves Patient-Reported Quality of Life
Transition to Subcutaneous Immune Globulin 16.5% Improves Patient-Reported Quality of Life
SUGAR LAND, TX – (July 1, 2022) Subcutaneous immune globulin (IGSC) is indicated for the treatment of primary immunodeficiences (PID) and offers the convenience of self-administration, fewer systemic reactions, and more stable IgG levels compared to intravenous IG...
Texas Neurological Society Summer Conference 2022
Texas Neurological Society Summer Conference 2022
San Antonio, TX The Healix Team is excited to exhibit at the upcoming Texas Neurological Society (TNS) Summer Conference in sunny San Antonio on July 22-23, 2022. If you're attending, come chat with our representative at the Healix booth #25 to learn how our...
NLA Scientific Sessions 2022
NLA Scientific Sessions 2022
Scottsdale, AZ The Healix Team looks forward to participating as an exhibitor at the National Lipid Association Scientific Sessions on June 2-5 as we showcase our premier injection and infusion management services for cardiology providers. Stop by the Healix booth...
GSR 2022 Annual Meeting
GSR 2022 Annual Meeting
Hilton Head Island, SC As a supporter of the Georgia Society of Rheumatology 2022 Annual Meeting, we are extremely grateful to showcase our leading infusion management solutions for Rheumatology providers June 3-5 at the Sonesta Resort Hilton Head Island. If you're...
CCR-East 2022
CCR-East 2022
Destin, FL The Healix team is thrilled to be headed to Destin in May attending the 2022 Congress of Clinical Rheumatology East Symposium (CCR-East) alongside the best and brightest in Rheumatology. Visit the Healix booth to learn about our industry-leading infusion...
The Impact of COVID-19 on Outpatient Intravenous Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers (POICs)
The Impact of COVID-19 on Outpatient Intravenous Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers (POICs)
SUGAR LAND, TX – (February 16, 2022) The coronavirus disease 2019 (COVID-19) pandemic dramatically affected the provision of healthcare in the U.S. with sharp declines in routine and elective healthcare services. A study evaluated how COVID-19 impacted the...
A 3-Year Evaluation of Antibiotic Resistance Patterns in Gram-Negative Genitourinary Tract Infections Treated in Outpatient Infusion Centers (POICs)
A 3-Year Evaluation of Antibiotic Resistance Patterns in Gram-Negative Genitourinary Tract Infections Treated in Outpatient Infusion Centers (POICs)
SUGAR LAND, TX – (February 16, 2022) Resistant Gram-negative pathogens (GNP) are a primary cause of many infections, particularly genitourinary tract infections (GUI). High recurrence rates and increasing antibiotic resistance often require intravenous antibiotics...
STAR 2022 Annual Meeting
STAR 2022 Annual Meeting
Houston, TX Meet with the Healix team at the State of Texas Association of Rheumatologists (STAR) 2022 Annual Meeting. Visit the Healix booth to learn how our office-based infusion services help rheumatology practices to provide a full continuum of care for...
AAAAI 2022 Annual Meeting
AAAAI 2022 Annual Meeting
Phoenix, AZ Healix is proud to participate in the upcoming 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Phoenix, Arizona. While attending the show, stop by the Healix booth #1443 to speak with a representative about how our...
ACAAI 2021 Annual Scientific Meeting
ACAAI 2021 Annual Scientific Meeting
New Orleans, LA Join the Healix team at the American College of Allergy, Asthma & Immunology (ACAAI) 2021 Annual Scientific Meeting. Stop by booth #746 to learn about how we help allergy, immunology, & pulmonology practices like yours provide a full...
Healix Collaborative Research at ACG 2021
Healix Collaborative Research at ACG 2021
Healix is proud to participate in collaborative research with our clients at the 2021 American College of Gastroenterology (ACG) Annual Meeting. While attending the conference, please visit the following Healix poster presentations on Monday, October 25 from 10:30...